Delstrigo Avrupa Birliği - Lehçe - EMA (European Medicines Agency)

delstrigo

merck sharp & dohme b.v. - doravirine, lamiwudyna, tenofowir disoproxil fumarate - infekcje hiv - leki przeciwwirusowe do leczenia zakażeń hiv, kombinacje - delstrigo jest wskazany w leczeniu osób dorosłych zakażonych hiv-1, bez przeszłych lub aktualnych dowodów opór klasy nnrti, lamiwudyną lub tenofowir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Rekambys Avrupa Birliği - Lehçe - EMA (European Medicines Agency)

rekambys

janssen-cilag international nv - rilpivirine - infekcje hiv - Środki przeciwwirusowe do użytku ogólnoustrojowego - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.